Skip to main content
Premium Trial:

Request an Annual Quote

Move Over, Bacteria …

Researchers at the Center for Systems Biology in Boston have discovered a new kind of immune cell, which may change the way the body's response to bacterial infection is studied, says New Scientist. The team's study, recently published in Science, describes innate response activator B-cells — IRA-B. The work shows that "this is a cell that plays a key role in the initiation of an immune response, not just in the production of antibodies," says researcher Filip Swirski. He and his team discovered the cells while looking for the source of growth factor GM-CSF, which also activates immune cells, New Scientist says. When the team injected mice with bacteria to provoke an immune response, they discovered that the CM-CSF growth factor was being generated by IRA-B cells. "The cells also seem to guard against sepsis," New Scientist adds. "Mice engineered to lack functional IRA-B cells were unable to clear bacteria, and died from sepsis."

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.